ℹ️
🇬🇧
Search
Search for people relevant for "Par proteins"
Par proteins
Person
Class
Person
Publication
Programmes
Export current view
RNDr. Pavol Szabo Ph.D.
Academic staff at First Faculty of Medicine
50 publications
Publications
publication
Aesculus hippocastanum L. Extract Does Not Induce Fibroblast to Myofibroblast Conversion but Increases Extracellular Matrix Production In Vitro Leading to Increased Wound Tensile Strength in Rats
2020 |
First Faculty of Medicine, Third Faculty of Medicine
publication
Microenvironment-driven resistance to B-Raf inhibition in a melanoma patient is accompanied by broad changes of gene methylation and expression in distal fibroblasts
2018 |
First Faculty of Medicine
publication
How signaling molecules regulate tumor microenvironment: parallels to wound repair
2017 |
First Faculty of Medicine
publication
Pharmacological activation of estrogen receptors-alpha and -beta differentially modulates keratinocyte differentiation with functional impact on wound healing
2016 |
First Faculty of Medicine
publication
Fibroblasts isolated from the malignant melanoma influence phenotype of normal human keratinocytes
2015 |
First Faculty of Medicine
publication
Revelation of fibroblast protein commonalities and differences and their possible roles in wound healing and tumourigenesis using co-culture models of cells
2014 |
First Faculty of Medicine
publication
Cultivation-dependent plasticity of melanoma phenotype
2013 |
First Faculty of Medicine
publication
Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: Increased expression of galectin-1 and induction of poor prognosis factors
2012 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Upregulation of IL-6, IL-8 and CXCL-1 production in dermal fibroblasts by normal/malignant epithelial cells in vitro: Immunohistochemical and transcriptomic analyses.
2012 |
First Faculty of Medicine
publication
Unravelling heterogeneous effects of cancer-associated fibroblasts on poor prognosis markers in breast cancer EM-G3 cell line: In vitro-targeted treatment (anti-IL-6, anti-VEGF-A, anti-MFGE8) based on transcriptomic profiling
2024 |
First Faculty of Medicine, Third Faculty of Medicine
Load more publications (40)
Loading network view...